Sanofi closes deal for consumer health unit Opella: Report MD Bureau21 Oct 2024 1:18 PM ISTThe breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the country
AstraZeneca gets CDSCO Panel nod to study Budesonide, Glycopyrronium and Formoterol Fumarate Dr. Divya Colin20 Oct 2024 5:45 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Gilead withdraws bladder cancer drug Trodelvy in US Farhat Nasim20 Oct 2024 11:00 AM ISTBengaluru: Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for previously treated patients with a type of bladder...
Merck eyes more acquisitions for life science after USD 600M Mirus Bio deal MD Bureau20 Oct 2024 10:15 AM ISTMerck also said it will intensify the in licensing of drug candidates in its Healthcare division.
CVS Health CEO steps down amid financial challenges MD Bureau20 Oct 2024 9:45 AM ISTCVS cut its financial expectations for the third time in August with all major pharmacy chains attempting to navigate a drastically changed landscape
Kezar to terminate mid-stage trial for Lupus treatment MD Bureau20 Oct 2024 9:30 AM ISTThe regulator's decision came after the company paused the study in September to review safety data following the deaths of four patients.
NPPA slaps over Rs 6L demand notice to Torrent Pharma MD Bureau19 Oct 2024 3:32 PM ISTThe demand notice is for the launch of a new drug wherein price approval was taken after the launch, Torrent Pharma said in a regulatory filing.
Gland Pharma names Shyamakant Giri as new CEO MD Bureau19 Oct 2024 3:29 PM ISTNew Delhi: Gland Pharma has announced a major leadership change with the appointment of Shyamakant Giri as the new Chief Executive Officer (CEO),...
Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Block Novo Holdings' USD16.5B Catalent acquisition: Consumer Groups Urge FTC over antitrust concerns MD Bureau19 Oct 2024 11:30 AM ISTThe deal could constrain options for competitors such as Amgen, Pfizer, Roche, and AstraZeneca , who are reportedly developing their own GLP 1 drugs.
Sage Therapeutics reshuffles leadership, cuts 165 jobs to focus on postpartum depression drug launch MD Bureau19 Oct 2024 10:30 AM ISTThe drugmaker plans to prioritize the launch of its postpartum depression pill Zurzuvae, that has been jointly developed with Biogen.
Cipla, Alkem vie for Rs 4,000 crore stake in India's largest stent manufacturer: Report Farhat Nasim18 Oct 2024 5:47 PM ISTMumbai: Pharmaceutical giants Cipla and Alkem Laboratories are in the final stages of a bidding war to acquire a controlling stake in Sahajanand...
